Two Sigma Investments
NVAX icon

Two Sigma Investments’s Novavax NVAX Stock Holding History

Two Sigma Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5M Sell
614,799
-9,013
-1% -$81.7K ﹤0.01% 1976
2025
Q4 		$4.19M Sell
623,812
-78,188
-11% -$589K 0.01% 1868
2025
Q3 		$6.09M Buy
702,000
+162,754
+30% +$1.27M 0.01% 1309
2025
Q2 		$3.4M Buy
539,246
+299,061
+125% +$1.98M 0.01% 1486
2025
Q1 		$1.54M Buy
240,185
+209,278
+677% +$1.73M ﹤0.01% 1903
2024
Q4 		$248K Sell
30,907
-730,029
-96% -$7.04M ﹤0.01% 2807
2024
Q3 		$9.61M Buy
760,936
+261,528
+52% +$3.38M 0.02% 776
2024
Q2 		$6.32M Buy
+499,408
New +$5.02M 0.01% 902
2023
Q2 		– Sell
-363,036
Closed -$2.52M – 3190
2023
Q1 		$2.52M Sell
363,036
-647,956
-64% -$5.96M 0.01% 1250
2022
Q4 		$10.4M Buy
+1,010,992
New +$17.8M 0.03% 540
2020
Q4 		– Sell
-144,079
Closed -$15.6M – 3625
2020
Q3 		$15.6M Buy
+144,079
New +$17.6M 0.06% 365
2019
Q3 		– Sell
-53,647
Closed -$314K – 3703
2019
Q2 		$314K Sell
53,647
-62,141
-54% -$489K ﹤0.01% 2840
2019
Q1 		$1.28M Sell
115,788
-48,340
-29% -$1.53M ﹤0.01% 1685
2018
Q4 		$6.04M Buy
164,128
+113,404
+224% +$4.4M 0.02% 718
2018
Q3 		$1.91M Sell
50,724
-40,517
-44% -$1.14M 0.01% 1517
2018
Q2 		$2.44M Buy
91,241
+78,869
+637% +$2.67M 0.01% 1480
2018
Q1 		$520K Buy
12,372
+3,692
+43% +$148K ﹤0.01% 2449
2017
Q4 		$215K Buy
+8,680
New +$212K ﹤0.01% 2893
2017
Q1 		– Sell
-1,618
Closed -$41K – 3187
2016
Q4 		$41K Buy
+1,618
New +$47.2K ﹤0.01% 3013
2016
Q3 		– Sell
-685
Closed -$100K – 3298
2016
Q2 		$100K Buy
+685
New +$78.5K ﹤0.01% 2821
2015
Q4 		– Sell
-25,669
Closed -$3.63M – 2890
2015
Q3 		$3.63M Buy
+25,669
New +$5.76M 0.02% 620
2013
Q4 		– Sell
-713
Closed -$45K – 2316
2013
Q3 		$45K Buy
+713
New +$40.2K ﹤0.01% 1785

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's NVAX Position: Q1 2026 in Review

Two Sigma Investments reduced its Novavax (NVAX) stake by 1.4% in Q1 2026, selling an estimated $81.7K and leaving 614,799 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Two Sigma Investments first reported a position in NVAX in Q3 2013 and has held it in 22 quarters since. The position peaked at $15.6M in Q3 2020. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Two Sigma Investments held 614,799 shares of Novavax worth $5M as of Q1 2026.
  • Two Sigma Investments sold 9,013 Novavax shares in Q1 2026, an estimated $81.7K.
  • Novavax made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1976 holding.
  • Two Sigma Investments first reported a position in Novavax in Q3 2013 and has held it in 22 quarters since.
  • Two Sigma Investments's Novavax position peaked at $15.6M in Q3 2020.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.